Missing/wrong data?
Log in to edit
Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea.
scientific article published on September 2015
Author/s
author: Jae Hee Cheon
Work details
Publication date
January 1, 2015
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.